Beta Bionics, Inc.
(NASDAQ: BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

16.890

+1.590 (+10.39%)
Range 15.220 - 17.000   (11.70%)
Open 15.310
Previous Close 15.300
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 753,041
Value -
Remark
Delayed prices. Updated at 22 Aug 2025 04:00.
Data powered by
View All Events

Share your investing ideas
Please login to view stock data and analysis